Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc. | 0 | 24 | 0 | 2 | €0.43 | - | - |
| Moleculin Biotech Inc | 3 | 26 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Arca Biopharma | 0 | 22 | 0 | 2 | €3.68 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Trevena Inc. | 2 | 14 | 1 | 1 | €0.36 | €6.48 | 1720.787% |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 2 | €0.97 | €3.00 | 210.238% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.28 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.34 | €3.00 | 28.205% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.91 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.96 | €6.49 | 574.449% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €4.12 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.58 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.55 | €3.00 | 443.675% |
| Fibrogen Inc. | 1 | 2 | 0 | 0 | €1.15 | €6.00 | 423.560% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.35 | - | - |
| Revance Therapeutics Inc. | 1 | 2 | 0 | 2 | €2.90 | €3.50 | 20.690% |
| Cytomx Therapeutics Inc | 1 | 2 | 1 | 2 | €1.84 | €25.50 | 1288.889% |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.94 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.15 | €58.50 | 718.182% |
| Applied Therapeutics Inc | 1 | 1 | 0 | 0 | €4.05 | €4.00 | -1.332% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.00 | €3.00 | 50.075% |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.69 | €6.43 | 834.520% |
| Inotiv Inc. | 2 | 1 | 0 | 0 | €1.97 | €10.66 | 441.203% |